Literature DB >> 18495744

Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?

Dorine W Swinkels1, Jack F M Wetzels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18495744     DOI： 10.1093/ndt/gfn267

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  21 in total

Review 1.  Applications of nanoparticles in the detection and treatment of kidney diseases.

Authors:  Chris Brede; Vinod Labhasetwar
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

2.  Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients.

Authors:  Taehee Kim; Elani Streja; Melissa Soohoo; Connie M Rhee; Rieko Eriguchi; Tae Woo Kim; Tae Ik Chang; Yoshitsugu Obi; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2017-07-14       Impact factor: 3.754

3.  Role of HAMP Genetic Variants on Pathophysiology of Iron Deficiency Anemia.

Authors:  S Pandey; S K Pandey; V Shah
Journal:  Indian J Clin Biochem       Date:  2017-11-20

Review 4.  Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.

Authors:  Jodie L Babitt; Herbert Y Lin
Journal:  Am J Kidney Dis       Date:  2010-02-26       Impact factor: 8.860

5.  Changes in Hepcidin and Hemoglobin After Anti-TNF-alpha Therapy in Children and Adolescents With Crohn Disease.

Authors:  Meredith A Atkinson; Mary B Leonard; Rita Herskovitz; Robert N Baldassano; Michelle R Denburg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

6.  Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.

Authors:  Lavinia Oltiţa Brătescu; Liliana Bârsan; Liliana Gârneaţă; Ana Stanciu; Mariana Lipan; Simona Hildegard Stancu; Gabriel Mircescu
Journal:  Int Urol Nephrol       Date:  2014-03-29       Impact factor: 2.370

7.  Time-of-flight mass spectrometry analysis of the ferroportin-hepcidin binding domain complex for accurate mass confirmation of bioactive hepcidin 25.

Authors:  David K Crockett; Mark M Kushnir; John D Phillips; Alan L Rockwood
Journal:  Clin Chim Acta       Date:  2009-12-03       Impact factor: 3.786

8.  Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

Authors:  Joshua Zaritsky; Brian Young; He-Jing Wang; Mark Westerman; Gordana Olbina; Elizabeta Nemeth; Tomas Ganz; Seth Rivera; Allen R Nissenson; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

9.  Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.

Authors:  Santhi K Ganesh; Neil A Zakai; Frank J A van Rooij; Nicole Soranzo; Albert V Smith; Michael A Nalls; Ming-Huei Chen; Anna Kottgen; Nicole L Glazer; Abbas Dehghan; Brigitte Kuhnel; Thor Aspelund; Qiong Yang; Toshiko Tanaka; Andrew Jaffe; Joshua C M Bis; Germaine C Verwoert; Alexander Teumer; Caroline S Fox; Jack M Guralnik; Georg B Ehret; Kenneth Rice; Janine F Felix; Augusto Rendon; Gudny Eiriksdottir; Daniel Levy; Kushang V Patel; Eric Boerwinkle; Jerome I Rotter; Albert Hofman; Jennifer G Sambrook; Dena G Hernandez; Gang Zheng; Stefania Bandinelli; Andrew B Singleton; Josef Coresh; Thomas Lumley; André G Uitterlinden; Janine M Vangils; Lenore J Launer; L Adrienne Cupples; Ben A Oostra; Jaap-Jan Zwaginga; Willem H Ouwehand; Swee-Lay Thein; Christa Meisinger; Panos Deloukas; Matthias Nauck; Tim D Spector; Christian Gieger; Vilmundur Gudnason; Cornelia M van Duijn; Bruce M Psaty; Luigi Ferrucci; Aravinda Chakravarti; Andreas Greinacher; Christopher J O'Donnell; Jacqueline C M Witteman; Susan Furth; Mary Cushman; Tamara B Harris; Jing-Ping Lin
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.